Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: IAM1363 in HER2 Cancers Primary completion pushed from Dec 2027 to Oct 2028
- Notable: Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection Primary completion pushed from Nov 2026 to Mar 2029
- Notable: SFL-0821 · FSHD Primary and study completion dates pushed to Aug 2029
- Notable: GC310 Injection · Wilson's Disease (WD) Primary completion pushed from Apr 2027 to Dec 2027
- Notable: HALOS · ION582 · Angelman Syndrome Primary and study completion pushed from Mar 2029 to Mar 2032
- Notable: KITE-363 · Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment Primary and study completion pushed from Jun 2029 to Dec 2031
- Notable: Using the 'Pivot Extend' System as a Treatment · Tricuspid Regurgitation Primary completion pushed from Apr 2026 to Nov 30, 2027
- Notable: DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity Primary completion pushed from Jun 5, 2026 to Dec 5, 2027
- Notable: Syde® Digital Endpoints for Monitoring · Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R) Primary and study completion pushed from Mar 2028 to Nov 2028
- Notable: Royal Ancient Oats™ Study Primary completion pushed from Jun 30, 2026 to Jun 30, 2027
- Notable: Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up Primary and study completion pushed from May 31, 2026 to Mar 30, 2027
- Notable: Binimetinib · BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer Primary completion pushed from Feb 28, 2027 to Feb 28, 2028
- Notable: Delivery Outcomes by AIDA (Artificial Intelligence Dystocia Algorithm) Analysis Primary completion pushed from Dec 30, 2025 to Aug 30, 2027
- Notable: Muscle Response to Different Amounts of Dietary Protein During Leg Immobilization Primary and study completion pushed from Sep 2026 to Apr 2027
- Notable: Treatment Costs of Kidney Injury in Patients Having Heart Surgery in the UK Primary and study completion pushed from Apr 1, 2027 to Dec 1, 2027
- Notable: Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood · Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study Primary and study completion pushed from Dec 31, 2030 to Dec 31, 2032
- Notable: Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) Primary completion pushed from May 2025 to May 2027
- Notable: Ixazomib Maintenance Study · AL Amyloidosis Primary and study completion pushed from Aug 2026 to Aug 2027
- Notable: Mitapivat Sulfate · Erythrocyte Membranopathies Primary completion pushed from Jul 15, 2025 to Sep 30, 2028
- Notable: Hybrid Robot+FES Stroke Rehabilitation Primary completion pushed from Oct 1, 2026 to Oct 1, 2027
- Notable: BCAA vs. Rifaximin · Cirrhosis for Secondary Prophylaxis of HE Primary completion pushed from Aug 2026 to Aug 2027
- Notable: Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma Primary completion pushed from Jul 1, 2028 to Jul 1, 2030
- Notable: Active Surveillance and Chemotherapy Before Surgery · Stage II-III Rectal Cancer Primary and study completion pushed from Oct 31, 2026 to Oct 31, 2028
- Notable: HSV G207 · Recurrent or Refractory Cerebellar Brain Tumors Primary and study completion dates pushed to Dec 31, 2027
- Notable: Antimicrobial Effect of Tropolone Containing Versus Tropolone Free Mouthwash Primary completion pushed from Oct 2026 to Oct 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates